AVHHL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (15 Apr 2024 @ 12:57):

Stats
Today's Volume	15.00
Average Volume	185.00
Market Cap	228.02M
EPS	$-34.30 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.50
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-03	Shiroma Donna	Buy	100 000	Stock Options (Right to Buy)
2023-11-30	Shiroma Donna	Buy	1 469	Common Stock
2024-01-03	O'toole David D	Buy	125 000	Stock Options (Right to Buy)
2023-12-26	Corbett James	Sell	1 445	Common
2023-12-21	Cook Jeremy Curnock	Sell	2 500	Common

INSIDER POWER
67.13
Last 51 transactions
Buy: 875 519 \| Sell: 317 706

AVITA Medical, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AVITA Medical, Inc. Financials

Annual	2022
Revenue:	$34.42M
Gross Profit:	$28.38M (82.45 %)
EPS:	$-0.240

Q3	2023
Revenue:	$13.65M
Gross Profit:	$11.53M (84.51 %)
EPS:	$-34.30

Q2	2023
Revenue:	$11.75M
Gross Profit:	$9.55M (81.25 %)
EPS:	$-0.0823

Q1	2023
Revenue:	$10.55M
Gross Profit:	$8.88M (84.20 %)
EPS:	$-0.0732

Financial Reports:

No articles found.

AVITA Medical, Inc.

AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.